Loading…
CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis
Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targe...
Saved in:
Published in: | Prostate cancer and prostatic diseases 2021-09, Vol.24 (3), p.891-902 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653 |
---|---|
cites | cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653 |
container_end_page | 902 |
container_issue | 3 |
container_start_page | 891 |
container_title | Prostate cancer and prostatic diseases |
container_volume | 24 |
creator | Capik, Ozel Sanli, Fatma Kurt, Ali Ceylan, Onur Suer, Ilknur Kaya, Murat Ittmann, Michael Karatas, Omer Faruk |
description | Background
Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells.
Methods
We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models.
Results
In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway.
Conclusion
In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis. |
doi_str_mv | 10.1038/s41391-021-00353-0 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2504351979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A673073115</galeid><sourcerecordid>A673073115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</originalsourceid><addsrcrecordid>eNp9kVFrFDEQx4Motla_gA-yIEhftk0ym2T38TjaWigIV30O2dzsXsrupiZZsd_ebK9aK1LCkJD5_Scz-RPyntETRqE-jRWDhpWU56AgoKQvyCGrlCyFpPXLfAYpSlULfkDexHhDKW1YQ1-TAwAloFbikGzWq-s1Y8Vt8KNPGAvT9wFjdD9wylvhuyUVk0lYWDNZDIXFYYhF2gU_97tidJuSVeL08uKcbQrz08W35FVnhojvHvYj8u387Ov6c3n15eJyvboqbaUglWDstutaqbiyqqFSIDWi2lojWYeGC-DKmFrVtuUM27bFmuVAnmdrmJQCjsjxvm5u8PuMMenRxaU5M6Gfo-aCViBYo5qMfvwHvfFzmHJ3mZLQgKygfqR6M6B2U-dTMHYpqldSAVXA2PLsyX-ovLY4Ousn7Fy-fyL49Jdgh2ZIu-iHOTk_xacg34M2_3gM2Onb4EYT7jSjenFc7x3X2XF977imWfThYbS5HXH7R_Lb4gzAHog5NfUYHmd_puwvuvCxrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563936438</pqid></control><display><type>article</type><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><source>Springer Nature</source><creator>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</creator><creatorcontrib>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</creatorcontrib><description>Background
Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells.
Methods
We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models.
Results
In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway.
Conclusion
In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/s41391-021-00353-0</identifier><identifier>PMID: 33753875</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>1-Phosphatidylinositol 3-kinase ; 13/106 ; 38/1 ; 38/109 ; 631/67/68 ; 692/699/67/68 ; 82 ; 82/80 ; 96 ; 96/63 ; AKT protein ; Analysis ; Apoptosis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Proliferation ; Colonies ; Developed countries ; Development and progression ; Gene Expression Regulation, Neoplastic ; Genes ; Health aspects ; Humans ; Lung cancer ; Male ; Malignancy ; MicroRNAs - genetics ; Molecular modelling ; Phenotypes ; Prognosis ; Prostate cancer ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Receptor, IGF Type 1 - genetics ; Receptor, IGF Type 1 - metabolism ; Reproductive Medicine ; RNA, Long Noncoding - genetics ; Signal transduction ; Signaling ; Therapeutic targets ; TOR protein ; Tumor Cells, Cultured</subject><ispartof>Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.891-902</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature Limited.</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</citedby><cites>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</cites><orcidid>0000-0002-0379-2088 ; 0000-0003-4802-0978</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33753875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Capik, Ozel</creatorcontrib><creatorcontrib>Sanli, Fatma</creatorcontrib><creatorcontrib>Kurt, Ali</creatorcontrib><creatorcontrib>Ceylan, Onur</creatorcontrib><creatorcontrib>Suer, Ilknur</creatorcontrib><creatorcontrib>Kaya, Murat</creatorcontrib><creatorcontrib>Ittmann, Michael</creatorcontrib><creatorcontrib>Karatas, Omer Faruk</creatorcontrib><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Background
Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells.
Methods
We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models.
Results
In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway.
Conclusion
In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>13/106</subject><subject>38/1</subject><subject>38/109</subject><subject>631/67/68</subject><subject>692/699/67/68</subject><subject>82</subject><subject>82/80</subject><subject>96</subject><subject>96/63</subject><subject>AKT protein</subject><subject>Analysis</subject><subject>Apoptosis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Proliferation</subject><subject>Colonies</subject><subject>Developed countries</subject><subject>Development and progression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Male</subject><subject>Malignancy</subject><subject>MicroRNAs - genetics</subject><subject>Molecular modelling</subject><subject>Phenotypes</subject><subject>Prognosis</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptor, IGF Type 1 - genetics</subject><subject>Receptor, IGF Type 1 - metabolism</subject><subject>Reproductive Medicine</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Signal transduction</subject><subject>Signaling</subject><subject>Therapeutic targets</subject><subject>TOR protein</subject><subject>Tumor Cells, Cultured</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kVFrFDEQx4Motla_gA-yIEhftk0ym2T38TjaWigIV30O2dzsXsrupiZZsd_ebK9aK1LCkJD5_Scz-RPyntETRqE-jRWDhpWU56AgoKQvyCGrlCyFpPXLfAYpSlULfkDexHhDKW1YQ1-TAwAloFbikGzWq-s1Y8Vt8KNPGAvT9wFjdD9wylvhuyUVk0lYWDNZDIXFYYhF2gU_97tidJuSVeL08uKcbQrz08W35FVnhojvHvYj8u387Ov6c3n15eJyvboqbaUglWDstutaqbiyqqFSIDWi2lojWYeGC-DKmFrVtuUM27bFmuVAnmdrmJQCjsjxvm5u8PuMMenRxaU5M6Gfo-aCViBYo5qMfvwHvfFzmHJ3mZLQgKygfqR6M6B2U-dTMHYpqldSAVXA2PLsyX-ovLY4Ousn7Fy-fyL49Jdgh2ZIu-iHOTk_xacg34M2_3gM2Onb4EYT7jSjenFc7x3X2XF977imWfThYbS5HXH7R_Lb4gzAHog5NfUYHmd_puwvuvCxrw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Capik, Ozel</creator><creator>Sanli, Fatma</creator><creator>Kurt, Ali</creator><creator>Ceylan, Onur</creator><creator>Suer, Ilknur</creator><creator>Kaya, Murat</creator><creator>Ittmann, Michael</creator><creator>Karatas, Omer Faruk</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0379-2088</orcidid><orcidid>https://orcid.org/0000-0003-4802-0978</orcidid></search><sort><creationdate>20210901</creationdate><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><author>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>13/106</topic><topic>38/1</topic><topic>38/109</topic><topic>631/67/68</topic><topic>692/699/67/68</topic><topic>82</topic><topic>82/80</topic><topic>96</topic><topic>96/63</topic><topic>AKT protein</topic><topic>Analysis</topic><topic>Apoptosis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Proliferation</topic><topic>Colonies</topic><topic>Developed countries</topic><topic>Development and progression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Male</topic><topic>Malignancy</topic><topic>MicroRNAs - genetics</topic><topic>Molecular modelling</topic><topic>Phenotypes</topic><topic>Prognosis</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptor, IGF Type 1 - genetics</topic><topic>Receptor, IGF Type 1 - metabolism</topic><topic>Reproductive Medicine</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Signal transduction</topic><topic>Signaling</topic><topic>Therapeutic targets</topic><topic>TOR protein</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Capik, Ozel</creatorcontrib><creatorcontrib>Sanli, Fatma</creatorcontrib><creatorcontrib>Kurt, Ali</creatorcontrib><creatorcontrib>Ceylan, Onur</creatorcontrib><creatorcontrib>Suer, Ilknur</creatorcontrib><creatorcontrib>Kaya, Murat</creatorcontrib><creatorcontrib>Ittmann, Michael</creatorcontrib><creatorcontrib>Karatas, Omer Faruk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Capik, Ozel</au><au>Sanli, Fatma</au><au>Kurt, Ali</au><au>Ceylan, Onur</au><au>Suer, Ilknur</au><au>Kaya, Murat</au><au>Ittmann, Michael</au><au>Karatas, Omer Faruk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><stitle>Prostate Cancer Prostatic Dis</stitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>24</volume><issue>3</issue><spage>891</spage><epage>902</epage><pages>891-902</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Background
Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells.
Methods
We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models.
Results
In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway.
Conclusion
In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33753875</pmid><doi>10.1038/s41391-021-00353-0</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0379-2088</orcidid><orcidid>https://orcid.org/0000-0003-4802-0978</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1365-7852 |
ispartof | Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.891-902 |
issn | 1365-7852 1476-5608 |
language | eng |
recordid | cdi_proquest_miscellaneous_2504351979 |
source | Springer Nature |
subjects | 1-Phosphatidylinositol 3-kinase 13/106 38/1 38/109 631/67/68 692/699/67/68 82 82/80 96 96/63 AKT protein Analysis Apoptosis Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Biomedical and Life Sciences Biomedicine Cancer Research Cell Proliferation Colonies Developed countries Development and progression Gene Expression Regulation, Neoplastic Genes Health aspects Humans Lung cancer Male Malignancy MicroRNAs - genetics Molecular modelling Phenotypes Prognosis Prostate cancer Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Receptor, IGF Type 1 - genetics Receptor, IGF Type 1 - metabolism Reproductive Medicine RNA, Long Noncoding - genetics Signal transduction Signaling Therapeutic targets TOR protein Tumor Cells, Cultured |
title | CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T16%3A46%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CASC11%20promotes%20aggressiveness%20of%20prostate%20cancer%20cells%20through%20miR-145/IGF1R%20axis&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Capik,%20Ozel&rft.date=2021-09-01&rft.volume=24&rft.issue=3&rft.spage=891&rft.epage=902&rft.pages=891-902&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/s41391-021-00353-0&rft_dat=%3Cgale_proqu%3EA673073115%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2563936438&rft_id=info:pmid/33753875&rft_galeid=A673073115&rfr_iscdi=true |